Donor KIR haplotype B improves progression-free and overall survival after allogeneic hematopoietic stem cell transplantation for multiple myeloma

被引：0
|
作者：
N Kröger
T Zabelina
J Berger
H Duske
E Klyuchnikov
T Binder
T Stübig
Y Hilde-brandt
D Atanackovic
H Alchalby
F Ayuk
A R Zander
U Bacher
T Eiermann
机构：
[1] Clinic for Stem Cell Transplantation,Department of Oncology/Hematology
[2] University Hospital Hamburg-Eppendorf,undefined
[3] Institute of Statistics,undefined
[4] University Medical Center,undefined
[5] University Hospital Hamburg-Eppendorf,undefined
[6] Institute for Transfusion Medicine,undefined
[7] University Medical Center,undefined
[8] University Hospital Hamburg-Eppendorf,undefined
[9] University Medical Center,undefined
[10] University Hospital Hamburg-Eppendorf,undefined
来源：
Leukemia | 2011年 / 25卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1657 / 1661
页数：4
相关论文
共 50 条
  • [1] Donor KIR haplotype B improves progression-free and overall survival after allogeneic hematopoietic stem cell transplantation for multiple myeloma
    Kroeger, N.
    Zabelina, T.
    Berger, J.
    Duske, H.
    Klyuchnikov, E.
    Binder, T.
    Stuebig, T.
    Hilde-Brandt, Y.
    Atanackovic, D.
    Alchalby, H.
    Ayuk, F.
    Zander, A. R.
    Bacher, U.
    Eiermann, T.
    [J]. LEUKEMIA, 2011, 25 (10) : 1657 - 1661
  • [2] Donor KIR-Haplotype B Improved Relapse-Free Survival After Allogeneic Stem Cell Transplantation for Multiple Myeloma
    Kroger, Nicolaus
    Duske, Heidi
    Zabelina, Tatjana
    Binder, Thomas
    Fehse, Boris
    Sezer, Orhan
    Stuebig, Thomas
    Hildebrandt, York
    Atanackovic, Djordje
    Zander, Axel R.
    Eiermann, Thomas
    [J]. BLOOD, 2010, 116 (21) : 983 - 983
  • [3] KIR genotype is associated with progression-free and overall survival following autologous stem cell transplantation for multiple myeloma
    Gabriel, I.
    Sargent, R.
    De Lavallade, H.
    Szydlo, R.
    Apperley, J.
    Khoder, A.
    Alsuliman, A.
    Marin, D.
    Foroni, L.
    Davis, J.
    Giles, C.
    Kanfer, E.
    Rahemtulla, A.
    Rezvani, K.
    [J]. BONE MARROW TRANSPLANTATION, 2010, 45 : S148 - S149
  • [4] Thalidomide plus dexamethasone as a maintenance therapy after autologous hematopoietic stem cell transplantation improves progression-free survival in multiple myeloma
    Maiolino, Angelo
    Hungria, Vania T. M.
    Garnica, Marcia
    Oliveira-Duarte, Gislaine
    Oliveira, Luciana C. O.
    Mercante, Daniel R.
    Miranda, Eliana C.
    Quero, Adriana A.
    Peres, Ana L. M.
    Barros, Jose C.
    Tanaka, Paola
    Magalhaes, Roberto P.
    Rego, Eduardo M.
    Lorand-Metze, Irene
    Lima, Carmen S. P.
    Renault, Ilana Z.
    Braggio, Esteban
    Chiattone, Carlos
    Nucci, Marcio
    de Souza, Carmino A.
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2012, 87 (10) : 948 - 952
  • [5] KIR genotype is associated with progression free and overall survival following autologous stem cell transplantation for multiple myeloma
    Gabriel, I. H.
    Sargent, R.
    de Lavallade, H.
    Szydlo, R.
    Apperley, J. F.
    Khodar, A.
    Alsuliman, A.
    Marin, D.
    Foroni, L.
    Davis, J.
    Giles, C.
    Kanfer, E.
    Rahemtulla, A.
    Rezvani, K.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2010, 149 : 19 - 19
  • [6] Second Autologous Stem Cell Transplantation as Salvage Therapy for Multiple Myeloma: Impact on Progression-Free and Overall Survival
    Jimenez-Zepeda, Victor H.
    Mikhael, Joseph
    Winter, Andrew
    Franke, Norman
    Masih-Khan, Esther
    Trudel, Suzanne
    Chen, Christine
    Kukreti, Vishal
    Reece, Donna E.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (05) : 773 - 779
  • [7] Bone Marrow Eosinophilia Correlates with Progression Free and Overall Survival After Allogeneic Hematopoietic Stem Cell Transplantation
    Georgieva, Y.
    Michova, A.
    Ganeva, P.
    Petrov, Y.
    Madzharova, V.
    Spassov, B.
    Balatzenko, G.
    Arnaudov, G.
    Mihaylov, G.
    Guenova, M.
    [J]. BONE MARROW TRANSPLANTATION, 2016, 51 : S444 - S445
  • [8] ANXIETY AND POSTTRAUMATIC GROWTH PREDICT PROGRESSION-FREE AND OVERALL SURVIVAL FOLLOWING AUTOLOGOUS STEM CELL TRANSPLANTATION FOR MULTIPLE MYELOMA
    Costanzo, Erin S.
    Rathouz, Paul J.
    Coe, Christopher L.
    Juckett, Mark B.
    Schwartz, Jessica R.
    Callander, Natalie S.
    [J]. PSYCHOSOMATIC MEDICINE, 2014, 76 (03) : A31 - A31
  • [9] The Value of Minimal Residual Disease as a Progression-Free Survival Predictor After Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma Patients
    Solovev, Maxim
    Mendeleeva, Larisa
    Firsova, Maiia
    Julhakyan, Hunan
    Galtseva, Irina
    Davydova, Julia
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 : S324 - S324
  • [10] Predictors of prolonged survival after allogeneic hematopoietic stem cell transplantation for multiple myeloma
    Bashir, Qaiser
    Khan, Hassan
    Orlowski, Robert Z.
    Amjad, Ali Imran
    Shah, Nina
    Parmar, Simrit
    Wei, Wei
    Rondon, Gabriela
    Weber, Donna M.
    Wang, Michael
    Thomas, Sheeba K.
    Shah, Jatin J.
    Qureshi, Sofia R.
    Dinh, Yvonne T.
    Popat, Uday
    Anderlini, Paolo
    Hosing, Chitra
    Giralt, Sergio
    Champlin, Richard E.
    Qazilbash, Muzaffar H.
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2012, 87 (03) : 272 - 276
12345